News
Dr. Jacques Genest, between good and bad cholesterol (IR-CUSM)
9 April 2018
General Public News
Jacques Genest is a world-renowned cardiologist and researcher who has focused his research on risk factors for cardiovascular disease, the genetics of coronary heart disease, and the formation of high-density lipoprotein (HDL). His research has, among other things, contributed to the identification of several genes involved in HDL metabolism, including the gene for ABCA1, the genetic cause of Tangier disease. Here are some public links for Dr. Genest’s research team (http://www.cardiomuhc.ca/jacques-genest):
For nearly 20 years, Dr. Genest has been involved in developing Canada’s cholesterol guidelines – guidelines.https://www.youtube.com/watch?v=6dQEirGGapk.
He has been involved in the design and implementation of several major clinical trials aimed at reducing the risk of cardiovascular disease (HOPE-2, homocysteine, JUPITER, REVEAL, IMPROVE-IT, ACCELERATE, CANTOS):
- https://ici.radio-canada.ca/premiere/emissions/les-annees-lumiere/segments/entrevue/36853/sante-cardiaque-canakinumab-statines (French text and audio)
- https://ici.radio-canada.ca/nouvelle/736609/hypercholesteremie-familiale-traitement-medicament-decouverte-mcgill (French text)
- http://ici.radio-canada.ca/emissions/rdi_week_end/2013-2014/Entrevue.asp?idDoc=347778 (French video)
He currently leads the Canadian HFCanada Family Hypercholesterolemia Registry. (www.FHCanada.net), a clinical network that aims to offer optimal treatment to patients with this disorder: http://www.providencehealthcare.org/news/20131213/st-pauls-hospital-cholesterol-registry-spawns-national-initiative
